Switching disease modifying agents in Multiple Sclerosis

Created using ChatSlide

Explore the intricacies of transitioning disease-modifying therapies (DMTs) in managing multiple sclerosis at this session. We will dissect the balance between optimal disease control and associated risks, guided by AAN and ECTRIMS/EAN recommendations. Key reasons for switching therapies include suboptimal responses, intolerable side effects, and the necessity for safer options during pregnancy. Understand types of treatment switches, including vertical escalation and horizontal changes. The...